There is a customer engagement revolution in motion in the life sciences industry as it faces life in the “new normal” after the peak of the patent cliff. The industry is in an era when targeting specific populations and improving patient outcomes is critical for specialty products and in which effectively reaching more customers in rapidly developing markets is paramount for growth.
This revolution requires companies to rethink how they can reach patients, payers, providers and governments in both mature and emerging markets—at speed, at the right price and with right information for each target audience.
There is also a need for better collaboration via numerous channels between pharmaceutical companies and physicians, payers, patients and care givers.
Infographic: Life Sciences Sales & Marketing Executives Survey Key Findings
Download Infographic [PDF, 167KB]